These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4285039)

  • 1. [Preliminary observations concerning the use of a synthetic delayed-action corticostimulin derivative (CIBA 36.716-Ba) in patients with asthma].
    Buytendijk HJ; Maesen F
    Acta Tuberc Pneumol Belg; 1965; 56(3):234-43. PubMed ID: 4285039
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic and therapeutic use of synthetic beta 1-24 corticotropin (30'920-BA Synacthen Ciba)].
    Horký K; Küchel O
    Vnitr Lek; 1968 Apr; 14(4):370-9. PubMed ID: 4298653
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of bronchial asthma with synthetic delayed-action corticotropin].
    Andersson E; Lorenzen J
    Nord Med; 1968 Aug; 80(32):1050-2. PubMed ID: 4301738
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trials with a new synthetic ACTH of prolonged action: Cortrosine Depot].
    Libon JC; Borlée J
    Rev Bras Med; 1971 Apr; 28(4):185-7. PubMed ID: 4330569
    [No Abstract]   [Full Text] [Related]  

  • 5. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients.
    Benos SA; Koutsoukos A; Sotirakis I; Pavlatos FC
    Acta Allergol; 1969 Sep; 24(3):178-86. PubMed ID: 4314190
    [No Abstract]   [Full Text] [Related]  

  • 6. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. I. Adrenocorticotropic and pituitary responsiveness following long-term intermittent administration.
    Benos SA; Koutsoukos A; Braouzi H; Georgopoulos A; Pavlatos FC
    Acta Allergol; 1969 Sep; 24(3):165-77. PubMed ID: 4314189
    [No Abstract]   [Full Text] [Related]  

  • 7. Elimination of severe height growth suppression caused by treatment with betamethasone after switching to ACTH-depot in chronic bronchial asthma.
    Moulaert AJ; Van Gemund JJ
    Helv Paediatr Acta; 1972 Apr; 21(1):55-62. PubMed ID: 4336638
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synthetic delayed-action ACTH in bronchial asthma].
    Szimak J
    Wien Med Wochenschr; 1971 Feb; 121(6):96-9. PubMed ID: 4322589
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current status of treatment with a synthetic corticotropic peptide, tetracosactide-retard].
    Deguillaume R
    Presse Med (1893); 1971 Jan; 79(6):233-5. PubMed ID: 4323028
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cortrosyn depot for treatment of asthmatic children].
    Schook JE; Schüller CF
    Ned Tijdschr Geneeskd; 1971 Aug; 115(34):1409-13. PubMed ID: 4327521
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synthetic depot-ACTH in the treatment of obstructive bronchial diseases].
    Frank A
    Wien Med Wochenschr; 1971 Nov; 121(47):844-8. PubMed ID: 4331890
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current perspectives in the control of bronchial asthma. Synacthen Depot].
    Cardoso R
    Hospital (Rio J); 1969 Oct; 76(4):1439-54. PubMed ID: 4312092
    [No Abstract]   [Full Text] [Related]  

  • 13. [Place of a delayed-action tetracosactide (synthetic cortico-stimulant) in treatment of obstructive bronchopathy].
    Uzzan D; Israel-Asselain R
    J Fr Med Chir Thorac; 1969; 23(5):561-72. PubMed ID: 4323669
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tetracosactide in the treatment of asthma].
    Bartsch P
    Acta Tuberc Pneumol Belg; 1970; 61(3):277-85. PubMed ID: 4324499
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of bronchial asthma using a synthetic beta 1-18 corticotropin derivative].
    Walser A; Keller R; Herzog H
    Schweiz Med Wochenschr; 1969 Nov; 99(48):1726-8. PubMed ID: 4312242
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of bronchial asthma using a synthetic beta 1-18-corticotropin derivative].
    Walser A; Keller R; Herzog H
    Helv Med Acta Suppl; 1969; 49():132-3. PubMed ID: 4315793
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacodynamic evaluation of synthetic prolonged-action ACTH on the adrenal function of patients with hypothalamo-pituitary pathology. Comparative study of synthetic ACTH and extra-delayed-action gel].
    Artese R; De Laszlo MH; Molocznik I; Varela J; Guitelman A; Brussino M; Dickmann GH; Montes ME
    Prensa Med Argent; 1971 Jan; 57(46):2088-97. PubMed ID: 4326359
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of bronchial asthma with synthetic long-term corticotrophin.
    Anderson E; Lorenzen J
    Scand J Respir Dis Suppl; 1970; 72():127. PubMed ID: 4320311
    [No Abstract]   [Full Text] [Related]  

  • 19. Children with steroid-dependent allergic asthma.
    Kamin PB; Fein BT
    Tex Med; 1967 Apr; 63(4):62-8. PubMed ID: 4292544
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypersensitivity to synthetic ACTH (Synacthen) in patients with bronchial asthma].
    Obtulowicz K; Glowacka A
    Pol Tyg Lek; 1974 Mar; 29(12):473-4. PubMed ID: 4362422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.